Cargando…

Incidence of testicular cancer in trans women using gender‐affirming hormonal treatment: a nationwide cohort study

OBJECTIVE: To assess the incidence of testicular cancer in trans women (male sex assigned at birth, female gender identity) using gender‐affirming hormonal treatment. PATIENTS AND METHODS: Data of trans women starting hormonal treatment at our gender identity clinic between 1972 and 2017 were linked...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Nie, Iris, Wiepjes, Chantal M., de Blok, Christel J.M., van Moorselaar, R. Jeroen A., Pigot, Garry L.S., van der Sluis, Tim M., Barbé, Ellis, van der Voorn, Patrick, van Mello, Norah M., Huirne, Judith, den Heijer, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291742/ https://www.ncbi.nlm.nih.gov/pubmed/34390620 http://dx.doi.org/10.1111/bju.15575

Ejemplares similares

Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone Treatment
por: de Nie, Iris, et al.
Publicado: (2020)

Fracture Risk in Trans Women and Trans Men Using Long‐Term Gender‐Affirming Hormonal Treatment: A Nationwide Cohort Study
por: Wiepjes, Chantal M, et al.
Publicado: (2019)

Bone Safety During the First Ten Years of Gender‐Affirming Hormonal Treatment in Transwomen and Transmen
por: Wiepjes, Chantal M, et al.
Publicado: (2018)

Frequency and outcomes of benign breast biopsies in trans women: A nationwide cohort study
por: de Blok, Christel JM., et al.
Publicado: (2021)

Successful restoration of spermatogenesis following gender-affirming hormone therapy in transgender women
por: de Nie, Iris, et al.
Publicado: (2023)

SAT416 The Incidence Of Autoimmune Disease In Transgender People After Initiation Of Gender-Affirming Hormone Therapy
por: Wiepjes, Chantal, et al.
Publicado: (2023)

Perineal Cyst in Transgender Men: A Rare Complication Following Gender Affirming Surgery – A Case Series and Literature Overview
por: Asseler, Joyce D., et al.
Publicado: (2021)

Impaired semen quality in trans women: prevalence and determinants
por: de Nie, I, et al.
Publicado: (2020)

Development of Hip Bone Geometry During Gender‐Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty
por: van der Loos, Maria ATC, et al.
Publicado: (2021)

OR31-06 Gender-Affirming Hormone Therapy Affects Serum Cystatin C-based eGFR In Transgender Individuals
por: van Eeghen, Sarah A, et al.
Publicado: (2023)

SAT411 The Influence Of Gender Affirming Hormone Therapy On Markers Of Platelet Activation In Transgender Women
por: van Zijverden, L Mees, et al.
Publicado: (2023)

OR31-01 The Dose-dependent Effect Of Estrogen On Bone Mineral Density In Trans Girls
por: Boogers, Lidewij S, et al.
Publicado: (2023)

Surgical outcomes of testicular prostheses implantation in transgender men with a history of prosthesis extrusion or infection
por: Legemate, Catherine M., et al.
Publicado: (2020)

Gender‐Affirming Hormone Treatment Decreases Bone Turnover in Transwomen and Older Transmen
por: Vlot, Mariska C, et al.
Publicado: (2019)

The effect of transdermal gender-affirming hormone therapy on markers of inflammation and hemostasis
por: Schutte, Moya H., et al.
Publicado: (2022)

Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands
por: de Blok, Christel J M, et al.
Publicado: (2019)

Surgical and demographic trends in genital gender-affirming surgery in transgender women: 40 years of experience in Amsterdam
por: van der Sluis, W B, et al.
Publicado: (2021)

Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long Term Follow up Study on Prevalence, Determinants, and the Effect of Years of Exposure
por: Madsen, Milou Cecilia, et al.
Publicado: (2021)

Response to Letter to the Editor From Laidlaw: “Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-term Follow-up Study on Prevalence, Determinants, and Exposure Years”
por: Madsen, Milou C, et al.
Publicado: (2021)

Mapping evidence on the effects of gender-affirming hormone therapy on the hard and soft tissues of the craniofacial complex in transgender people: a protocol for a scoping review
por: Van den Bosch, M. F., et al.
Publicado: (2021)

Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years
por: Madsen, Milou Cecilia, et al.
Publicado: (2021)

Gender-affirmation surgery and bariatric surgery in transgender individuals in The Netherlands: Considerations, surgical techniques and outcomes
por: van der Sluis, Wouter B., et al.
Publicado: (2021)

Surgical outcomes and proposal for a treatment algorithm for urethral strictures in transgender men
por: de Rooij, Freek P. W., et al.
Publicado: (2021)

Comparison of surgical outcomes and urinary functioning after phalloplasty with versus without urethral lengthening in transgender men
por: de Rooij, Freek P. W., et al.
Publicado: (2022)

Histological study on the influence of puberty suppression and hormonal treatment on developing germ cells in transgender women
por: de Nie, I, et al.
Publicado: (2021)

Change in grip strength in trans people and its association with lean body mass and bone density
por: Scharff, Miranda, et al.
Publicado: (2019)

Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study
por: Kuijpers, Suzanne M E, et al.
Publicado: (2021)

Just as Tall on Testosterone; a Neutral to Positive Effect on Adult Height of GnRHa and Testosterone in Trans Boys
por: Willemsen, Lieve Anne, et al.
Publicado: (2022)

Development of Hip Bone Geometry in Transgender Adolescents Resembles the Experienced Gender if GnRHa Treatment Is Started in Early, but Not Late, Puberty
por: van der Loos, Maria A T C, et al.
Publicado: (2021)

Change in Visceral Fat and Total Body Fat and the Effect on Cardiometabolic Risk Factors During Transgender Hormone Therapy
por: Klaver, Maartje, et al.
Publicado: (2021)

Double flap phalloplasty in transgender men: Surgical technique and outcome of pedicled anterolateral thigh flap phalloplasty combined with radial forearm free flap urethral reconstruction
por: van der Sluis, Wouter B., et al.
Publicado: (2017)

Incident Diabetes Risk Is Not Increased in Transgender Individuals Using Hormone Therapy
por: van Velzen, Daan, et al.
Publicado: (2021)

Combining total laparoscopic hysterectomy and bilateral salpingo-oophorectomy with subcutaneous mastectomy in trans men: The effect on safety outcomes
por: Elfering, Lian, et al.
Publicado: (2020)

Progesterone in gender-affirming therapy of trans women
por: Milionis, Charalampos, et al.
Publicado: (2022)

Effect of gender‐affirming hormone use on coagulation profiles in transmen and transwomen
por: Scheres, Luuk J.J., et al.
Publicado: (2021)

Trends in suicide death risk in transgender people: results from the Amsterdam Cohort of Gender Dysphoria study (1972–2017)
por: Wiepjes, C. M., et al.
Publicado: (2020)

Developing Trans-Affirming Health Services in an Underserved Area: An Intersectional Approach
por: Loza, Oralia, et al.
Publicado: (2018)

Brain responses to negated and affirmative meanings in the auditory modality
por: Farshchi, Sara, et al.
Publicado: (2023)

The effect of colpectomy on lower urinary tract function in transgender men
por: de Rooij, Freek P. W., et al.
Publicado: (2022)

“You Have to Wait a Little Longer”: Transgender (Mental) Health at Risk as a Consequence of Deferring Gender-Affirming Treatments During COVID-19
por: van der Miesen, Anna I. R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aab8uca12pk42aaaljupr4o1pf